Novartis in trouble in India
Talk about being stuck between a rock and a hard place; but what is Novartis supposed to do about its current problems over patents relating to its cancer treatment Glivec (Gleevec) in India? As the company must have expected, it is now facing a…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Register now
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe now